Light Therapy Market Size, Share and Analysis By Type (Red Light, Blue Light, White Light, and Others), By Application (Seasonal Affecting Disorder, Skin Disorder, Sleep Disorder, and Others), By Product (Face Masks, Light Lamps, and Light Box), and By End-User (Home Settings, Clinics, and Spas), and Regional Forecast, 2024-2032

Phototherapy, or light therapy, is a treatment that involves the use of an artificial light source. The therapy is mostly used to treat the seasonal affective disorder, or SAD caused due to lack of sunlight. The increasing prevalence of seasonal affective disorder (SAD) and mood disorders such as, depression, anxiety, and bipolar disorder are responsible for the rising demand for light therapy. According to an article published in MedlinePlus, the seasonal affective disorder affects around 0.5% to 3% of the general population. Seasonal affective disorder affects 10-20% of people with major depressive disorder and 25% of people with bipolar disorder.

The light therapy market is driven by increased partnerships by key players to introduce new products to cater to the rising need for light therapy for the treatment of various diseases such as sleep disorders, mood disorders including SAD. In addition, awareness is increasing among the general population and they have started taking mental health seriously and seeking treatments for mental disorders like SAD and it is anticipated to drive the growth of the light therapy market.

Nowadays, people are concerned about aesthetic appearance and spend huge amounts of money for light therapy treatment. Apart from this, rising prevalence of skin disorders such as, acne, eczema, and psoriasis along with availability of products through online platforms are resulting in the increase in demand for treatment options and significantly driving the market.

Impact of COVID-19 on the Light Therapy Market

The COVID-19 pandemic is expected to boost the growth of the global phototherapy market during the forecast period due to the increasing number of cases of anxiety, depression, and insomnia in COVID-19 patients owing to rising demand for light therapy for the treatment. According to WHO the global prevalence of anxiety and depression increased by 25% during COVID-19 pandemic.

Key Insights

The report will cover the following key insights:

• Prevalence of mood disorders- for key countries/ regions.


• Prevalence of skin disorders- for key countries/ regions.


• New product launches, by key players.


• Impact of COVID-19 on the light therapy market .

Analysis by Type

White light segment is expected to drive the market due to the rising prevalence of seasonal affective disorder globally, owing to the growing demand for light therapy among the patient pool for the treatment of seasonal affective disorder. Along with this, many players are introducing new white light therapies in the market is driving the segment growth.

Analysis by Application

The seasonal affective disorder segment is expected to drive the market due to rising demand owing to the new product launches by key players in the market.

• In April 2019, Koninklijke Philips N.V., launched the multi-component solution VitalMinds for reducing ICU delirium patients. The solution includes a light therapy system called VitalSky, which offers a circadian effective program.

Analysis by Product

Among the product segment, the facemask segment is expected to drive the market growth. Rising prevalence of mood disorders and skin disorders, the introduction of new products in the market and improved reimbursement policies are the major factors responsible for the segment growth globally.

• According to the British Journal of Dermatology, the prevalent cases of acne vulgaris is 231.2 million globally in 2019, an increase of 48.0% as compared to 1990.

Analysis by End User

Among the end user segment, home settings is expected to drive the segment growth due to the rising demand for light therapy among patients. The rising demand is due its user-friendliness, its effectiveness in treating the mood disorders and skin disorders, as well as cost effectiveness.

Regional Analysis

North America accounts for the largest share of the global light therapy market due to the rising demand for light therapy due to growing prevalence of seasonal affective disorder and mood disorders in the region. Along with this, the rising awareness rising among the general population regarding the new effective treatment options for the seasonal affective disorders, skin disorders, and sleep disorders will augment the market share.

• According to National Alliance on Medical Illness report, in 2020, 21% of adults in the United States suffer from mental illness (52.9 million people). This equates to 1 out of every 5 adults.


• According to American Academy of Dermatology Association, in the U.S. more than 50 million people gets affected by acne each year.

Key Players Covered

The report will include the profiles of key players such as Verilux, Inc., Carex, Northern Light Technologies, beurer, BioPhotas, Lumie, Koninklijke Philips N.V., Johnson & Johnson Services, Inc., LightStim and among others.

Segmentation

Key Industry Developments

• In February 2021, BioPhotas extended its product line of the Celluma series of light therapy devices, along with opening of its new sales office in London to expand its services.


• In December 2019, LightStim collaborated with AestheticSource to launch the LightStim in the UK market.